PURA Announces December Sales Surge As EVERx Distribution Continues To Expand
DALLAS, Dec. 06, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Puration, Inc. () (“PURA”) today announced continued distribution expansion of its EVERx CBD Sports water with hemp-derived CBD. EVERx will now be available at the Illegal Burger restaurant chain in the Denver area, offering hand-crafted burgers with full bar service and El Senor Sol, a fast-casual Mexican restaurant chain also in the Denver area. PURA recently announced 400% revenue growth through the 3rd quarter of 2018 reporting $868,000 in sales with a 50% profit margin. Earlier this week PURA announced a new distribution agreement in the Southeastern United Sates with an initial shipment of EVERx en route. Puration also recently announced a $1 million agreement to produce a new private labeled CBD infused bottled water for a health care industry firm.
Illegal Burger and El Senor Sol are subsidiaries of West Coast Ventures Group Corp. (). Illegal Burger was recently recognized for its same store year over year growth outpacing all its competition as announced in National Restaurant News. Now Illegal Burger and El Senor Sol will lead the way by introducing CBD infused beverages to the menu.
Puration launched the EVERx CBD Sports Waters in the spring of 2017. The company's sales grew 600% in the first year after the launch of EVERx. Kiwi Strawberry and Lemon Lime flavors are now available in addition the Original EVERx CBD Infused Sports Water. EVERx has more than twice the CBD of most CBD infused waters on the market. A proprietary technology enables EVERx to suspend more CBD than its competitors and still have a crystal-clear appearance and a refreshing taste.
Puration has the sole license for beverage production of U.S. Patent No. 9,199,960 entitled 'METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT'. The patent is owned by Puration partner Kali, Inc. () and Kali is currently working with Puration in the formulation of multiple extract concentrates that would enable Puration to produce a variety of private label CBD beverages with different CBD concentrates.
For more information on Puration, visit .
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.